Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a 'replacement for reading glasses' & due to possible health risks.
All India Ophthalmological Society has set up expert group to review PresVu & develop guidelines on side-effects, keeping in mind 'potential inappropriate marketing, indiscriminate use'.
The eye drop, made by Entod Pharmaceuticals, was launched Tuesday in India under the brand name PresVu. but it will have no impact on near-sightedness or myopia.'
Launched Tuesday by Entod Pharmaceuticals under brand name PresVu, eye drop will treat presbyopia, an age-related condition causing blurry vision. To be available across India by October.
Contrary to naysayers, the RSS practices what it preaches. It is closer to the Gandhian teaching of improving the individual morally and spiritually to change the external environment.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS